X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction

J Drugs Dermatol. 2010 May;9(5):562-4.

Abstract

Due to the mutations in the nicotinamide dinucleotide phosphate (NADPH) oxidase complex in X-linked chronic granulomatous disease (CGD), the phagocytic activity in these patients is curtailed by a dysfunctional respiratory burst. This can lead to life-threatening bacterial and fungal infections. The prognosis for patients with CGD has dramatically improved with the advent of effective prophylactic drugs targeting catalase-positive bacteria, opportunistic Gram-negative bacteria and fungi. Voriconazole, a second-generation triazole, is a commonly used agent for prophylaxis in this population. The authors report a case of photoaging and photosensitivity reaction associated with voriconazole exposure in a 10-year-old boy with X-linked CGD. With broad-spectrum sunscreen, topical steroids, and discontinuation of voriconazole, the patient showed significant improvement.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / adverse effects*
  • Antifungal Agents / therapeutic use
  • Child
  • Granulomatous Disease, Chronic / complications*
  • Humans
  • Male
  • Photosensitivity Disorders / chemically induced
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Serratia Infections / drug therapy
  • Serratia Infections / etiology
  • Skin Aging / drug effects
  • Triazoles / adverse effects*
  • Triazoles / therapeutic use
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole